Related Experiment Video
Updated: Oct 1, 2025

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Acute Myocarditis From the Use of Selective Androgen Receptor Modulator (SARM) RAD-140 (Testolone)
Rana Prathap Padappayil1, Arundhati Chandini Arjun1, Jonathan Vivar Acosta1
1Internal Medicine, Monmouth Medical Center, Long Branch, USA.
Selective Androgen Receptor Modulators (SARMs) may offer alternatives for hypogonadism. However, this case highlights potential cardiac risks, like myocarditis, associated with SARM misuse in bodybuilding.
Area of Science:
- Endocrinology
- Cardiology
- Pharmacology
Background:
- Selective Androgen Receptor Modulators (SARMs) are compounds targeting androgen receptors.
- SARMs are investigated as potential therapies for conditions like hypogonadism.
- Their use for non-medical purposes, such as bodybuilding, is prevalent but unregulated.
Observation:
- A young male presented with symptoms suggestive of acute myocarditis.
- The patient reported recent self-medication with a SARM for bodybuilding purposes.
- This clinical presentation raised concerns about the cardiac safety of SARMs.
Findings:
- The case links SARM self-administration to a potential diagnosis of acute myocarditis.
- This suggests a possible adverse cardiovascular effect of SARMs when used without medical supervision.
- Further investigation into SARM-induced cardiotoxicity is warranted.
Implications:
- This case underscores the potential health risks associated with the non-prescribed use of SARMs.
- It highlights the need for increased awareness among athletes and bodybuilders regarding SARM dangers.
- Clinicians should consider SARM use when evaluating young individuals with unexplained cardiac events.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis I: Introduction
Testosterone: Functions and Regulation
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction

